Organon & Co (OGN)
Organon & Co. is a health care company, focused on improving the health of women throughout their lives. Co. develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars and established brands. Co. has a portfolio of medicines and products across a range of therapeutic areas. Co. sells these products through various channels including drug wholesalers and retailers, hospitals, government agencies and managed health care providers such as health maintenance organizations, pharmacy benefit managers and other institutions. Co. operates manufacturing facilities located in Belgium, Brazil, Indonesia, Mexico, the Netherlands and the U.K.
OGN SEC Filing Email Alerts Service
Company Name: |
Organon & Co |
Website: |
www.organon.com |
Sector: |
Drugs & Pharmaceuticals |
Number of ETFs Holding OGN: |
67 |
Total Market Value Held by ETFs: |
$1.09B |
Total Market Capitalization: |
$4.78B |
% of Market Cap. Held by ETFs: |
22.78% |
|
|
April 28, 2024 11:51 AM Eastern
Hold (2.43 out of 4)
2nd percentile
|
|